Imiglucerase structure

Patent WO2011066352A1 – An amorphous and a crystalline, Glycan structures of velaglucerase alfa and imiglucerase, Patent EP2084519B1 – X-ray fluorescence analysis method, Products List Page – Pharmacodia, 2010 New Drug Approvals – Pt. IV – Velaglucerase Alfa (VPRIV), Characterization of gene activated human acid glucosidase, Characterization of gene activated human acid glucosidase, Background. N-linked glycan composition of recombinant, World Drug Tracker, Characterization of gene activated human acid glucosidase, Characterization of gene activated human acid glucosidase, Characterization of gene activated human acid glucosidase, Characterization of gene activated human acid glucosidase.